Illumina To Webcast Upcoming Investor Conference
Illumina (NASDAQ: ILMN) announced that its executives will present at the J.P.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Illumina (NASDAQ: ILMN) announced that its executives will present at the J.P. Morgan Annual Healthcare Conference on January 10, 2022. The presentation is set for 12:45 PM PT, followed by a Q&A session starting around 1:05 PM PT. Interested parties can access the live webcast via the Investor Info section on illumina.com. A replay will be available for at least 30 days post-event. Illumina continues to lead in DNA sequencing and array-based technologies, impacting various sectors such as life sciences and clinical markets.
Details
News Market Reaction – ILMN
The recorded move for ILMN in the trading session of this news was +0.62%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN DIEGO, Dec. 23, 2021 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that its executives will be speaking at the following investor conference:
- J.P. Morgan Annual Healthcare Conference on January 10, 2022
Presentation at 12:45pm Pacific Time (3:45pm Eastern Time) immediately followed by a Q&A Session to begin at approximately 1:05pm Pacific Time (4:05pm Eastern Time)
The live webcast can be accessed under the Investor Info section of the "company" tab at www.illumina.com. A replay will be posted on Illumina's website after the event and will be available for at least 30 days following.
About Illumina
Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments. To learn more, visit www.illumina.com and connect with us on Twitter, Facebook, LinkedIn, Instagram, and YouTube.
Investors:
Salli Schwartz
+1.858.291.6421
ir@illumina.com
Media:
Dr. Karen Birmingham
+1.646.355.2111
kbirmingham@illumina.com
View original content:https://www.prnewswire.com/news-releases/illumina-to-webcast-upcoming-investor-conference-301450546.html
SOURCE Illumina, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.